Year-end Sale % OFF 
Abstract
In their systematic review and meta-analysis in The Lancet Respiratory Medicine, Yves Lacasse and colleagues1 reviewed six randomised controlled trials, published between 1992 and 2020, reporting the effects of oxygen therapy in patients with chronic obstructive pulmonary disease (COPD) and moderate hypoxaemia. Lacasse and colleagues conclude that “home oxygen probably makes little or no difference to 3-year mortality in patients with COPD and moderate hypoxaemia. The data do not support the widespread use of home oxygen in this patient population.”1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
